ProCare Rx Earns Full URAC Reaccreditation in Pharmacy Benefit Management

The ProCare Rx Team • December 12, 2024

URAC accreditation reflects ProCare Rx’s commitment to achieving and maintaining the highest quality, member engagement and experience, and operational standards for PBMs in the industry

Gainesville, GA, December 12, 2024 - ProCare Rx, a leading provider of pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) solutions that reduce plan sponsor and employee pharmacy costs and improve clinical outcomes, has received full URAC reaccreditation for our Pharmacy Benefit Management Services supporting our affiliated PBM offerings as well as those of their clients. The organization and its affiliates have been URAC accredited since 2010. In addition to earning. In addition to earning accreditations or certifications from URAC for PBM and Mail Order Pharmacy, and HITRUST, ProCare Rx holds NIST SP 800-53 cybersecurity standard, and AICPA SOC 1 Type 2 and SOC 2 Type 2 + HIPAA certifications.


“Gaining URAC Pharmacy Benefit Management accreditation is a tremendous accomplishment and is reflective of the efforts of the many dedicated professionals involved in the process at ProCare Rx,” said Marileny Lugo, President MC-Rx. ProCare Rx Chief Executive Officer Barbara Rambo added, “2025 marks the 10th year under the ProCare Rx name in the US and the 15th year under the MC-Rx/MC21 name in Puerto Rico, that our overall solution has been accredited. I am incredibly proud of everyone throughout the organization who has contributed to bringing the highest level of commitment to our industry, clients, employees, and the lives we cover, delivering clinical-based outcomes.“


ProCare Rx offers programs that bring the appropriate balance of cost management and plan management to your organization, and illuminates the way to savings for everyone. At a time when satisfaction with traditional PBMs is at the lowest level in a decade, ProCare Rx will continue to raise the bar with ClearSight Transparency – a clear, direct look into your data, pricing, and claims cost. Built upon a foundation that has supported pass-through pharmacy benefit model since the beginning, the ProCare Rx organization helps to ensure that a maximum network cost savings and, other benefits are available to its plan sponsor clients. The URAC Pharmacy Benefit Management seal shows an organization’s commitment to high quality in healthcare in the areas of risk management, consumer protection and empowerment, operations and infrastructure, as well as performance management and improvement. We are proud to recognize ProCare Rx / MC-Rx for their achievement in these areas,” said URAC President and CEO, Shawn Griffin, MD.


To learn more about ProCare Rx’s suite of pharmacy benefit solutions, please visit www.procarerx.com.







About URAC



Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC  develops its evidence-based standards in collaboration with a wide array of stakeholders and  industry experts. The company’s portfolio of accreditation and certification programs spans the  health care industry, addressing health equity, workplace mental health, health care  management and operations, pharmacies, telehealth, health plans, medical practices and more.  URAC accreditation is a symbol of excellence for organizations to showcase their validated  commitment to quality and accountability.



To learn more about URAC’s stringent standards and evaluation process for PBMs, please visit

https://www.urac.org/accreditation-cert/pharmacy-benefit-management-accreditation/

About ProCare Rx
ProCare Rx is a privately held, independent pharmacy benefit manager (PBM) that has empowered healthcare and self-insured organizations since 1988. We provide fully integrated, in-house solutions—including claims adjudication, clinical program design, pharmacy network access, cost containment, and data analytics—all supported in the U.S. Our flexible, transparent model serves self-insured employers, third-party administrators (TPA), brokers, health plans, health systems, managed care organizations (MCO), unions, workers’ compensation programs, Medicare, Medicaid, hospices, and other PBMs. With a proprietary technology platform, commitment to ethical operations, and a focus on lowest net cost, ProCare Rx delivers long-term value, clinical performance, and trusted pharmacy benefit partnerships.

Media Contact:
Marc Cohen, VP, Marketing and Sales
marketing@ProCareRx.com

By ProCare Rx Team July 8, 2025
Prescription Drug Pricing: Will Policy Fix What Patients Feel?
By ProCare Rx Team June 2, 2025
Is Your PBM Working for You…Or Against You? How to Ask the Right Questions and Spot Red Flags in Pharmacy Benefit Management
By ProCare Rx May 20, 2025
ProCare Rx Announces New Executive Appointment and Launch of Technology Division to Drive Innovation and Growth The newly created role is expected to solidify leadership of the core technology infrastructure to both enhance support for current clients as well as developing additional value-added offerings to the marketplace.
By ProCare Rx Team May 19, 2025
Understanding the “Most Favored Nation” Drug Pricing Rule
By ProCare Rx Team May 19, 2025
ProCare Rx's Innovative Approach to Pharmacy Benefit Management
By ProCare Rx May 6, 2025
ProCare Rx Appoints John Drakulich as President of their PBM Business
By ProCare Rx Team April 21, 2025
ProCare Rx’s ProCare PharmacyCare, LLC Earns URAC Accreditation in Specialty Pharmacy
By ProCare Rx Team April 15, 2025
Prescription Drug Reform Gains Momentum: What the New Senate Bill Means for Plan Sponsors
By ProCare Rx Team April 2, 2025
The White House recently launched the Make America Healthy Again Commission to address some of the biggest challenges in U.S. healthcare—including chronic disease, medication reliance, and drug safety. While the full impact remains to be seen, this initiative signals potential shifts in how prescription drugs are evaluated, priced, and prescribed. For plan sponsors, employers, and pharmacy benefits managers (PBMs), the key question is: How can we ensure medication access, affordability, and safety while staying ahead of possible regulatory changes? Reevaluating Medication Reliance One of the Commission’s focus areas is over-reliance on medication and treatments. This could lead to a push for more careful prescribing practices, increased scrutiny of high-cost drugs, and expanded support for alternative treatment methods. PBMs can play a proactive role by ensuring plan designs promote clinically effective, cost-conscious prescribing, including: Encouraging use of generics and biosimilars when available Implementing clinical programs that support appropriate prescribing Providing medication management resources to help members navigate treatment options Increased Attention on Drug Safety & Pricing The Commission also highlights food and drug quality and safety , reinforcing the need for greater transparency in pharmaceutical manufacturing and pricing . This could mean: Tighter regulations on imported medications and supply chain oversight More scrutiny on rebate structures and how drug prices are set A renewed focus on affordability strategies for plan sponsors and consumers For PBMs and health plans, transparent pricing models and clear rebate structures will be key to staying compliant and ensuring members have access to safe, fairly priced medications. Eliminating Conflicts of Interest in Health Research Another priority for the Commission is ensuring federally funded health research is free from conflicts of interest . This could impact how drug effectiveness is studied, how formularies are built, and how treatment guidelines are developed. Employers and health plans should work with PBMs that prioritize: Data-driven formulary management based on independent clinical outcomes Objective drug evaluations to balance cost and effectiveness Transparent partnerships with health providers and pharmaceutical companies What’s Next? The Make America Healthy Again Commission is still in its early stages, but its focus on medication reliance, drug safety, and pharmaceutical pricing should not be ignored. Employers and plan sponsors should be prepared for potential policy changes that could impact pharmacy benefits. By working with PBMs that prioritize clinical integrity, cost control, and member education , organizations can stay ahead of the curve and continue to provide high- quality, affordable healthcare solutions. Would you like to review your pharmacy benefits strategy? Let’s talk. Click the button below to learn more about ProCare Rx's Offering and signup to hear from one of our sales team.
By ProCare Rx Team March 3, 2025
FTC Report Reveals $7.3 Billion in Excessive PBM Revenues—What It Means for Employers and Patients
More Posts